Dr. Leonid Poretsky, MD

Dr. Poretsky practices at Northwell Health Physician Partners Cardiology in New York, New York.

Dr. Poretsky's NPI, 1962491811, was assigned on October 13, 2005. Dr. Poretsky graduated from St Petersburg Medical State Academy in 1977. Dr. Poretsky holds New York license 155121.

Dr. Poretsky's primary practice is Northwell Health Physician Partners Cardiology, at 110 E 59th St, New York, NY 10022 in New York County. The practice phone is (516) 321-7400.

Dr. Poretsky's primary practice is Northwell Health Physician Partners Cardiology in New York, New York. Dr. Poretsky is also affiliated with Lenox Hill Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Poretsky to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poretsky practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Poretsky's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Poretsky is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Poretsky's licenses on file in 5 states: New York, California, Massachusetts, Pennsylvania and Maryland.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, high cholesterol, obesity, osteoporosis, overactive thyroid and parathyroid gland disorder among the conditions Dr. Poretsky treats.

CMS data shows 1,071 Medicare services from Dr. Poretsky across 7 procedure codes in 2024, for 180 Medicare patients. Medicare paid $41,350 for them. Every service was in an office.

CMS counts 180 Medicare patients who saw Dr. Poretsky in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Poretsky's median patient age at 67, with 53% women.

In 2024, Dr. Poretsky wrote 74 Medicare Part D claims for 29 patients. 54% of them were for generic drugs. CMS names the drug for 37 of them, across 2 drugs with 11 or more claims each, at $29,518 in total drug cost. In 2022, CMS named 119 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Poretsky for performance year 2024, reported through an alternative payment model (APM). Dr. Poretsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Poretsky as offering telehealth.

Dmand AI links 94 papers to Dr. Poretsky, published from 2005 to 2024. 2019 was the busiest year, with 7. The most frequent topics are Insulin, Ovary and Insulin Resistance. Dr. Poretsky has published most often in J Clin Endocrinol Metab. Dr. Poretsky's most frequent co-authors are Zev Rosenwaks, MD, Takako Araki, MD and Emilia P. Liao, MD.

Dmand AI links Dr. Poretsky to 1 clinical trial. Conditions studied include Prediabetic State and Diabetes Mellitus, Type 2.

CMS Open Payments shows 14 general payments to Dr. Poretsky from 7 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 81% of the total. Sanofi and Genzyme US Companies paid the most, $6,470.

Dmand AI lists 2 awards for Dr. Poretsky.

Dr. Poretsky graduated from St Petersburg Medical State Academy in 1977. Dr. Poretsky is a member of AACE and ENDO.

Dr. Poretsky is in network with 16 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.